PUBLISHER: Renub Research | PRODUCT CODE: 1313765
PUBLISHER: Renub Research | PRODUCT CODE: 1313765
Transcatheter Heart Valve Replacement Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
Global Transcatheter Heart Valve Market is estimated to be US$ 15.14 Billion in 2030, according to Renub Research. Over the past decade, the number of bio-prosthetic valve implants has steadily increased, leading to a growing population of patients who may require reoperation due to valve deterioration. In response, valve-in-valve transcatheter aortic valve replacement has emerged as a safe and effective alternative to surgery, specifically approved for higher-risk, inoperable patients. This complex procedure requires skilled personnel and should be performed in specialized centers to mitigate the higher risk of peri- and post-procedural complications compared to TAVR on native valves.
Aortic stenosis, a condition where the aortic valve doesn't fully open, restricts blood flow and necessitates treatment such as transcatheter aortic valve implantation. The rising prevalence of aortic stenosis, coupled with improved surgical techniques and growing demand for surgical technologies, is driving the transcatheter aortic valve replacement (TAVR) market. Increased healthcare investments, globally, are further supporting the market's expansion. Additionally, factors such as the growing acceptance rate of TAVI treatments, new device approvals, and a wealth of clinical evidence on their success are propelling market demand.
Global transcatheter aortic valve replacement (TAVR) market is projected to experience a strong compound annual growth rate (CAGR) of 12.73% from 2022 to 2030
The global transcatheter heart valve replacement market is witnessing significant growth due to the rise in the prevalence of valvular heart diseases and the increasing demand for minimally invasive procedures. The aging population, particularly those affected by heart valve diseases, is driving the need for valve replacement surgeries. Advancements in surgical techniques are further contributing to the growth of the transcatheter heart valve replacement market. Favorable reimbursement policies and the growing interest of manufacturers are also boosting market revenue.
However, strict regulations for the approval of transcatheter aortic valves and the high cost of TAVI procedures pose challenges to market expansion. Nevertheless, the use of TAVI systems for new indications, increased healthcare spending in emerging economies, and the involvement of key players in the global TAVI industry are expected to create growth opportunities throughout the forecast period. The global transcatheter aortic valve implantation market was valued at US$ 5.81 Billion in 2022.
Market share of TAVR is expected to continue its upward trajectory in the global healthcare landscape
By Type, Transcatheter Heart Valve Replacement Market is divided into TAVR, TMVR and TPVR. Transcatheter Aortic Valve Replacement (TAVR) has emerged as a leading procedure in the global medical market, capturing the highest market share. The increasing prevalence of cardiovascular diseases, particularly aortic valve disorders, has contributed to the rising demand for TAVR procedures. This minimally invasive technique offers numerous benefits, including reduced hospital stay, faster recovery time, and improved patient outcomes.
Moreover, advancements in TAVR device technologies, coupled with the growing acceptance of this procedure among healthcare professionals, have further fueled its market dominance. With ongoing research and development efforts and a favorable reimbursement landscape, the TAVR market is projected to maintain its significant market share in the foreseeable future.
Biological tissue market segment is experiencing rapid growth within the Transcatheter Aortic Valve Replacement (TAVR) industry
By Material, Transcatheter Heart Valve Replacement Market is segmented into Mechanical valves and Biological tissue. The biological tissue market within the Transcatheter Aortic Valve Replacement (TAVR) industry is experiencing rapid growth and emerging as the fastest-growing segment. Biological tissue valves, also known as bioprosthetic valves, offer advantages such as improved durability and reduced risk of blood clots compared to mechanical valves. This has led to increased adoption of biological tissue valves in TAVR procedures, especially among elderly patients who require valve replacement. The market growth is further fueled by advancements in tissue engineering, which have led to the development of more durable and long-lasting biological tissue valves. With ongoing research and technological innovations, the biological tissue market is poised to continue its upward trajectory within the TAVR industry.
Growing prominence of ASCs is expected to reshape the landscape of TAVR and drive its rapid expansion in the coming years
By End User, Transcatheter Heart Valve Replacement Market is classified into Hospital, Ambulatory surgical centers and others. The ambulatory surgical centers (ASCs) segment is emerging as the fastest growing sector within the Transcatheter Aortic Valve Replacement (TAVR) industry. ASCs provide a convenient and cost-effective alternative to traditional hospital settings for performing TAVR procedures.
With advancements in medical technology and improved patient outcomes, more TAVR procedures can now be safely conducted in outpatient settings. ASCs offer shorter hospital stays, reduced healthcare costs, and greater accessibility for patients. Additionally, ASCs focus on delivering specialized care and personalized patient experiences, attracting more physicians and patients to choose these centers for TAVR procedures.
Transcatheter Aortic Valve Replacement (TAVR) industry in India is rapidly evolving and witnessing significant growth
By Countries, Transcatheter Heart Valve Replacement Market is breakup into US, Canada, Mexico, Brazil, Argentina, Germany, Spain, United Kingdom, Italy, France, Indonesia, Malaysia, India, Thailand, Japan, China, South Korea, Australia, New Zealand, South Africa, Saudi Arabia, UAE, Turkey and Rest of the world. The United States Transcatheter Aortic Valve Replacement (TAVR) industry is experiencing significant growth and innovation. With a rising prevalence of aortic valve diseases and an aging population, TAVR has emerged as a preferred alternative to traditional open-heart surgery.
The market is driven by advanced medical technologies, a robust healthcare infrastructure, and a favorable reimbursement landscape. Major medical device companies, research institutions, and healthcare providers are actively engaged in expanding TAVR procedures and improving patient outcomes. Continuous advancements in device design, minimally invasive techniques, and clinical research are propelling the growth of the United States TAVR industry, positioning it as a global leader in this life-saving procedure.
With a large population and increasing prevalence of aortic valve diseases, there is a growing need for advanced treatment options like TAVR. The market is characterized by a rising number of medical institutions offering TAVR procedures, advancements in healthcare infrastructure, and increased awareness among healthcare professionals and patients. Government initiatives and favorable reimbursement policies are further fueling the growth of the TAVR industry in India. With continuous advancements in technology, increasing collaborations with international medical device companies, and ongoing research and development efforts, the Indian TAVR industry is poised for significant expansion and plays a vital role in improving cardiac care in the country.
Key Company
In the Valve Replacement (TAVR) industry, several key players have emerged as industry leaders. Edwards Life Sciences, Abbott Laboratories, Medtronic Plc, LIVANOVA PLC, Boston Scientific Corporation, Artivion, Inc, MicroPort Scientific Corporation, and Venus Medtech (Hangzhou) Inc are among the prominent companies driving innovation and advancements in this field.
Renub Research latest report "Transcatheter Heart Valve Replacement Market Global Forecast by Type (Transcatheter Aortic Valve Replacement Market, Transcatheter Mitral Valve Replacement Market and Transcatheter Pulmonary Valve Replacement Market), Material (Mechanical Valve, Biological Valve), Country (US, Canada, Mexico, Brazil, Argentina, Germany, Spain, United Kingdom, Italy, France, Indonesia, Malaysia, India, Thailand, Japan, China, South Korea, Australia, New Zealand, South Africa, Saudi Arabia, UAE, Turkey and Rest of the world), End-Users (Hospitals,Ambulatory surgical centres, others), Company (Edwards Life sciences, Abbott Laboratories, Medtronic Plc, LIVANOVA PLC, Boston Scientific Corporation, Artivion, Inc, MicroPort Scientific Corporation and Venus Medtech (Hangzhou) Inc.)" provides a detailed analysis of Global Transcatheter Heart Valve Replacement Industry.
Transcatheter Heart Valve Replacement Market by Type has been covered from 3 viewpoints
- 1. Transcatheter Aortic Valve Replacement
- 2. Transcatheter Mitral Valve Replacement
- 3. Transcatheter Pulmonary Valve Replacement
Transcatheter Aortic Valve Replacement Market has been covered from 2 viewpoints
- 1. Mechanical Valve
- 2. Biological Valve
Transcatheter Mitral Valve Replacement Market has been covered from 2 viewpoints
- 1. Mechanical Valve
- 2. Biological Valve
Transcatheter Pulmonary Valve Replacement Market has been covered from 2 viewpoints
- 1. Mechanical Valve
- 2. Biological Valve
By Country - Transcatheter Heart Valve Replacement Market
- 1. North America
- 1.1. United States
- 1.2. Canada
- 2. Latin America
- 2.1. Mexico
- 2.2. Brazil
- 2.3. Argentina
- 3. Europe
- 3.1. Germany
- 3.2. Spain
- 3.3. United Kingdom
- 3.4. Italy
- 3.5. France
- 3.6. Turkey
- 4. Asia Pacific
- 4.1. Indonesia
- 4.2. Malaysia
- 4.3. India
- 4.4. Thailand
- 4.5. Japan
- 4.6. China
- 4.7. South Korea
- 4.8. Australia
- 4.9. New Zealand
- 5. Middle East & Africa
- 5.1. South Africa
- 5.2. Saudi Arabia
- 5.3. UAE
- 6. Rest of the World
Transcatheter Heart Valve Replacement Market by End-User has been covered from 3 viewpoints
- 1. Hospital
- 2. Ambulatory surgical centers
- 3. Others
Company Insights
- Overviews
- Recent Developments
- Revenues
Company:
- 1. Edwards Life sciences
- 2. Abbott Laboratories
- 3. Medtronic Plc
- 4. LIVANOVA PLC
- 5. Boston Scientific Corporation
- 6. Artivion, Inc,
- 7. MicroPort Scientific Corporation
- 8. Venus Medtech (Hangzhou) Inc.
Table of Contents
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenge
5. Transcatheter Heart Valve Replacement Market
6. Share Analysis - Transcatheter Heart Valve Replacement Market
- 6.1 THVR Market Share by Type
- 6.2 THVR Market Share by Material
- 6.3 THVR Market Share by End User
- 6.4 THVR Market Share by Countries
- 6.5 TAVR Market Share by Product
- 6.6 TAVR Market Share by Application
7. Type - Transcatheter Heart Valve Replacement Market
- 7.1 TranscatheterAortic Valve Replacement
- 7.2 Transcatheter MitralValve Replacement
- 7.3 Transcatheter PulmonaryValve Replacement
8. Material - Transcatheter Heart Valve Replacement Market
- 8.1 Mechanical valves
- 8.2 Biological Valves
9. End-User - Transcatheter Heart Valve Replacement Market
- 9.1 Hospitals
- 9.2 Ambulatory Surgical Centers
- 9.3 Others
10. Countries - Transcatheter Aortic Heart Valve Replacement Market
- 10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.2 Latin America
- 10.2.1 Mexico
- 10.2.2 Brazil
- 10.2.3 Argentina
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 Spain
- 10.3.3 United Kingdom
- 10.3.4 Italy
- 10.3.5 France
- 10.3.6 Turkey
- 10.4 Asia Pacific
- 10.4.1 Indonesia
- 10.4.2 Malaysia
- 10.4.3 India
- 10.4.4 Thailand
- 10.4.5 Japan
- 10.4.6 China
- 10.4.7 South Korea
- 10.4.8 Australia
- 10.4.9 New Zealand
- 10.5 Middle East & Africa
- 10.5.1 South Africa
- 10.5.2 Saudi Arabia
- 10.5.3 UAE
- 10.6 Rest of the World
11. Product - Transcatheter Aortic Heart Valve Replacement Market
- 11.1 Transfemoral approach
- 11.2 Transapical approach
- 11.3 Transaortic approach
- 11.4 Others
12. Application - Transcatheter Aortic Heart Valve Replacement Market
- 12.1 Aortic Stenosis
- 12.2 Aortic Regurgitation
- 12.3 Others
13. Porter's Five Forces Analysis - Transcatheter Heart Valve Replacement Market
- 13.1 Bargaining Power of Buyers
- 13.2 Bargaining Power of Suppliers
- 13.3 Degree of Rivalry
- 13.4 Threat of New Entrants
- 13.5 Threat of Substitutes
14. SWOT Analysis - Transcatheter Heart Valve Replacement Market
- 14.1 Strength
- 14.2 Weakness
- 14.3 Opportunity
- 14.4 Threat
15. Key Players Analysis
- 15.1 Edwards Lifesciences
- 15.1.1 Overview
- 15.1.2 Recent Development
- 15.1.3 SWOT Analysis
- 15.1.4 Sales Analysis
- 15.2 Abbott Laboratories
- 15.2.1 Overview
- 15.2.2 Recent Development
- 15.2.3 SWOT Analysis
- 15.2.4 Sales Analysis
- 15.3 Medtronic Plc
- 15.3.1 Overview
- 15.3.2 Recent Development
- 15.3.3 SWOT Analysis
- 15.3.4 Sales Analysis
- 15.4 LIVANOVA PLC
- 15.4.1 Overview
- 15.4.2 Recent Development
- 15.4.3 SWOT Analysis
- 15.4.4 Sales Analysis
- 15.5 Boston Scientific Corporation
- 15.5.1 Overview
- 15.5.2 Recent Development
- 15.5.3 SWOT Analysis
- 15.5.4 Sales Analysis
- 15.6 Artivion, Inc.
- 15.6.1 Overview
- 15.6.2 Recent Development
- 15.6.3 SWOT Analysis
- 15.6.4 Sales Analysis
- 15.7 MicroPort Scientific Corporation
- 15.7.1 Overview
- 15.7.2 Recent Development
- 15.7.3 SWOT Analysis
- 15.7.4 Sales Analysis
- 15.8 Venus Medtech (Hangzhou) Inc
- 15.8.1 Overview
- 15.8.2 Recent Development
- 15.8.3 SWOT Analysis
- 15.8.4 Sales Analysis
List of Figures
- Figure-01: Global Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-02: Global - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-03: Type - Transcatheter Aortic Valve Replacement Market Market (Million US$), 2018 - 2022
- Figure-04: Type - Forecast for Transcatheter Aortic Valve Replacement Market Market (Million US$), 2023 - 2030
- Figure-05: Type - Transcatheter Mitral Valve Replacement Market Market (Million US$), 2018 - 2022
- Figure-06: Type - Forecast for Transcatheter Mitral Valve Replacement Market Market (Million US$), 2023 - 2030
- Figure-07: Type - Transcatheter Pulmonary Valve Replacement Market Market (Million US$), 2018 - 2022
- Figure-08: Type - Forecast for Transcatheter Pulmonary Valve Replacement Market Market (Million US$), 2023 - 2030
- Figure-09: Material - Mechanical Valve Market (Million US$), 2018 - 2022
- Figure-10: Material - Forecast for Mechanical Valve Market (Million US$), 2023 - 2030
- Figure-11: Material - Biological Valve Market (Million US$), 2018 - 2022
- Figure-12: Material - Forecast for Biological Valve Market (Million US$), 2023 - 2030
- Figure-13: End-User - Hospitals Market (Million US$), 2018 - 2022
- Figure-14: End-User - Forecast for Hospitals Market (Million US$), 2023 - 2030
- Figure-15: End-User - Ambulatory Surgical Centers Market (Million US$), 2018 - 2022
- Figure-16: End-User - Forecast for Ambulatory Surgical Centers Market (Million US$), 2023 - 2030
- Figure-17: End-User - Others Market (Million US$), 2018 - 2022
- Figure-18: End-User - Forecast for Others Market (Million US$), 2023 - 2030
- Figure-19: United States - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-20: United States - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-21: Canada - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-22: Canada - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-23: Mexico - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-24: Mexico - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-25: Brazil - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-26: Brazil - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-27: Argentina - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-28: Argentina - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-29: Germany - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-30: Germany - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-31: Spain - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-32: Spain - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-33: United Kingdom - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-34: United Kingdom - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-35: Italy - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-36: Italy - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-37: France - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-38: France - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-39: Turkey - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-40: Turkey - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-41: Indonesia - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-42: Indonesia - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-43: Malaysia - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-44: Malaysia - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-45: India - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-46: India - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-47: Thailand - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-48: Thailand - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-49: Japan - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-50: Japan - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-51: China - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-52: China - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-53: South Korea - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-54: South Korea - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-55: Australia - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-56: Australia - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-57: New Zealand - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-58: New Zealand - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-59: South Africa - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-60: South Africa - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-61: Saudi Arabia - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-62: Saudi Arabia - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-63: UAE - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-64: UAE - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-65: Rest of the World - Transcatheter Heart Valve Replacement Market (Million US$), 2018 - 2022
- Figure-66: Rest of the World - Forecast for Transcatheter Heart Valve Replacement Market (Million US$), 2023 - 2030
- Figure-67: Product - Transfemoral Approach Market (Million US$), 2018 - 2022
- Figure-68: Product - Forecast for Transfemoral Approach Market (Million US$), 2023 - 2030
- Figure-69: Product - Transapical Approach Market (Million US$), 2018 - 2022
- Figure-70: Product - Forecast for Transapical Approach Market (Million US$), 2023 - 2030
- Figure-71: Product - Transaortic Approach Market (Million US$), 2018 - 2022
- Figure-72: Product - Forecast for Transaortic Approach Market (Million US$), 2023 - 2030
- Figure-73: Product - Others Market (Million US$), 2018 - 2022
- Figure-74: Product - Forecast for Others Market (Million US$), 2023 - 2030
- Figure-75: Application - Aortic Stenosis Market (Million US$), 2018 - 2022
- Figure-76: Application - Forecast for Aortic Stenosis Market (Million US$), 2023 - 2030
- Figure-77: Application - Aortic Regurgitation Market (Million US$), 2018 - 2022
- Figure-78: Application - Forecast for Aortic Regurgitation Market (Million US$), 2023 - 2030
- Figure-79: Application - Others Market (Million US$), 2018 - 2022
- Figure-80: Application - Forecast for Others Market (Million US$), 2023 - 2030
- Figure-81: Edwards Lifesciences - Global Revenue (Million US$), 2018 - 2022
- Figure-82: Edwards Lifesciences - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-83: Abbott Laboratories - Global Revenue (Million US$), 2018 - 2022
- Figure-84: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-85: Medtronic Plc - Global Revenue (Million US$), 2018 - 2022
- Figure-86: Medtronic Plc - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-87: LIVANOVA PLC - Global Revenue (Million US$), 2018 - 2022
- Figure-88: LIVANOVA PLC - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-89: Boston Scientific Corporation - Global Revenue (Million US$), 2018 - 2022
- Figure-90: Boston Scientific Corporation - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-91: Artivion, Inc. - Global Revenue (Million US$), 2018 - 2022
- Figure-92: Artivion, Inc. - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-93: MicroPort Scientific Corporation - Global Revenue (Million US$), 2018 - 2022
- Figure-94: MicroPort Scientific Corporation - Forecast for Global Revenue (Million US$), 2023 - 2030
- Figure-95: Venus Medtech (Hangzhou) Inc - Global Revenue (Million US$), 2018 - 2022
- Figure-96: Venus Medtech (Hangzhou) Inc - Forecast for Global Revenue (Million US$), 2023 - 2030
List of Tables
- Table-01: Global - Transcatheter Heart Valve Replacement Market Share by Type (Percent), 2018 - 2022
- Table-02: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by Type (Percent), 2023 - 2030
- Table-03: Global - Transcatheter Heart Valve Replacement Market Share by Material (Percent), 2018 - 2022
- Table-04: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by Material (Percent), 2023 - 2030
- Table-05: Global - Transcatheter Heart Valve Replacement Market Share by End-User (Percent), 2018 - 2022
- Table-06: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by End-User (Percent), 2023 - 2030
- Table-07: Global - Transcatheter Heart Valve Replacement Market Share by Countries (Percent), 2018 - 2022
- Table-08: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by Countries (Percent), 2023 - 2030
- Table-09: Global - Transcatheter Heart Valve Replacement Market Share by Product (Percent), 2018 - 2022
- Table-10: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by Product (Percent), 2023 - 2030
- Table-11: Global - Transcatheter Heart Valve Replacement Market Share by Application (Percent), 2018 - 2022
- Table-12: Global - Forecast for Transcatheter Heart Valve Replacement Market Share by Application (Percent), 2023 - 2030
